Adlai Nortye ANL
NASDAQ ANL
$15.65 +0.25 (+1.62%)
At close: Sep 29, 2026 · 4:00 PM EDT

Adlai Nortye (ANL) Notes Payables (2022 - 2026)

Updated

Adlai Nortye (ANL) recorded Notes Payables of $17.62 million in Q2 2026, down 60.0% from $44.05 million a year earlier.

Analysis

Adlai Nortye (ANL) Notes Payables (2022 - 2026) Analysis & Trends

At the end of FY2025, Adlai Nortye reported Notes Payables of $24.58 million, down 6.6% from FY2024.

  • Annual Notes Payables has a three-year compound annual growth rate of 78.7% (FY2022 to FY2025).
  • Across earlier years, Notes Payables came in at $26.33 million in FY2024 (-13.3%), $30.36 million in FY2023 (+604.8%) and $4.31 million in FY2022.
  • The Q2 2026 figure is the lowest quarterly Notes Payables since Q4 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 Adlai Nortye 528.79 Mn 429.49 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 17.62 Mn
Dec 31, 2025 24.58 Mn
Jun 30, 2025 44.05 Mn
Dec 31, 2024 26.33 Mn
Jun 30, 2024 38.89 Mn
Dec 31, 2023 -602,000.00
Dec 31, 2022 -292,000.00
API Access

Adlai Nortye Notes Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=notes-payables&ticker=ANL&period=max&api_key=YOUR_API_KEY